GLPG
Price
$28.73
Change
-$0.05 (-0.17%)
Updated
May 23 closing price
Capitalization
1.9B
59 days until earnings call
MTNB
Price
$0.80
Change
+$0.03 (+3.90%)
Updated
May 23, 04:48 PM (EDT)
Capitalization
3.92M
Interact to see
Advertisement

GLPG vs MTNB

Header iconGLPG vs MTNB Comparison
Open Charts GLPG vs MTNBBanner chart's image
Galapagos
Price$28.73
Change-$0.05 (-0.17%)
Volume$210.69K
Capitalization1.9B
Matinas Biopharma Holdings
Price$0.80
Change+$0.03 (+3.90%)
Volume$250
Capitalization3.92M
GLPG vs MTNB Comparison Chart
Loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLPG vs. MTNB commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPG is a Hold and MTNB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 25, 2025
Stock price -- (GLPG: $28.73 vs. MTNB: $0.77)
Brand notoriety: GLPG and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLPG: 51% vs. MTNB: 156%
Market capitalization -- GLPG: $1.9B vs. MTNB: $3.92M
GLPG [@Biotechnology] is valued at $1.9B. MTNB’s [@Biotechnology] market capitalization is $3.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLPG’s FA Score shows that 0 FA rating(s) are green whileMTNB’s FA Score has 1 green FA rating(s).

  • GLPG’s FA Score: 0 green, 5 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, MTNB is a better buy in the long-term than GLPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLPG’s TA Score shows that 6 TA indicator(s) are bullish while MTNB’s TA Score has 4 bullish TA indicator(s).

  • GLPG’s TA Score: 6 bullish, 4 bearish.
  • MTNB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than MTNB.

Price Growth

GLPG (@Biotechnology) experienced а +3.53% price change this week, while MTNB (@Biotechnology) price change was -11.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

GLPG is expected to report earnings on Jul 23, 2025.

MTNB is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($1.9B) has a higher market cap than MTNB($3.92M). MTNB YTD gains are higher at: 50.980 vs. GLPG (4.473). MTNB has higher annual earnings (EBITDA): -21.05M vs. GLPG (-127.75M). GLPG has more cash in the bank: 3.3B vs. MTNB (10.8M). MTNB has less debt than GLPG: MTNB (3.07M) vs GLPG (10.9M). GLPG has higher revenues than MTNB: GLPG (288M) vs MTNB (0).
GLPGMTNBGLPG / MTNB
Capitalization1.9B3.92M48,455%
EBITDA-127.75M-21.05M607%
Gain YTD4.47350.9809%
P/E Ratio53.70N/A-
Revenue288M0-
Total Cash3.3B10.8M30,528%
Total Debt10.9M3.07M355%
FUNDAMENTALS RATINGS
GLPG vs MTNB: Fundamental Ratings
GLPG
MTNB
OUTLOOK RATING
1..100
3350
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9196
PRICE GROWTH RATING
1..100
4644
P/E GROWTH RATING
1..100
60100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (26) in the Biotechnology industry is somewhat better than the same rating for GLPG (74). This means that MTNB’s stock grew somewhat faster than GLPG’s over the last 12 months.

MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GLPG (100). This means that MTNB’s stock grew similarly to GLPG’s over the last 12 months.

GLPG's SMR Rating (91) in the Biotechnology industry is in the same range as MTNB (96). This means that GLPG’s stock grew similarly to MTNB’s over the last 12 months.

MTNB's Price Growth Rating (44) in the Biotechnology industry is in the same range as GLPG (46). This means that MTNB’s stock grew similarly to GLPG’s over the last 12 months.

GLPG's P/E Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for MTNB (100). This means that GLPG’s stock grew somewhat faster than MTNB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLPGMTNB
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
50%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRETX11.25N/A
N/A
Goldman Sachs Real Estate Securities Inv
EICVX17.77-0.01
-0.06%
EIC Value A
GGOSX9.98-0.02
-0.20%
Goldman Sachs Mid Cap Growth Svc
FVDKX36.70-0.09
-0.24%
Fidelity Value Discovery K
JUEAX24.08-0.15
-0.62%
JPMorgan US Equity A

GLPG and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
-0.17%
VCYT - GLPG
43%
Loosely correlated
-1.63%
RGNX - GLPG
37%
Loosely correlated
+0.73%
BEAM - GLPG
36%
Loosely correlated
-2.26%
NTLA - GLPG
36%
Loosely correlated
-3.17%
AXON - GLPG
35%
Loosely correlated
-0.55%
More

MTNB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with EQ. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then EQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
N/A
EQ - MTNB
38%
Loosely correlated
+5.43%
ABCZF - MTNB
37%
Loosely correlated
N/A
SPRC - MTNB
35%
Loosely correlated
+4.34%
AXON - MTNB
34%
Loosely correlated
-0.55%
VKTX - MTNB
32%
Poorly correlated
-2.70%
More